University of Toronto at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Toronto brings 12 presentations to ASH 2026 in New Orleans. Its program spans thalassemia, sickle cell disease, lymphoma and transfusion medicine. It includes a session on long-term thalassemia care and a hematology education curriculum project.
| Organization | ASH 2026 Attendance |
|---|---|
University of Toronto Toronto, Canada | |
Public research university in Toronto, Ontario, affiliated with the city's major teaching hospitals. | Oral Sat Dec 12 12:00pm–1:30pm Session Sat Dec 12 4:00pm–5:15pm Longer Lives, New Challenges: Managing Thalassemia in 2026 Challenges as people with thalassemia live longer, including pregnancy, cheaper and safer gene therapy, and aging with the non-transfusion-dependent form. Talk Sat Dec 12 4:00pm–5:15pm Pregnancy in Transfusion-Dependent and Non-Transfusion Dependent Thalassemia (TDT and NTDT) Pregnancy risks for women with thalassemia, whether or not they need regular transfusions, and team-based care from pre-conception counseling to after delivery. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 4:30pm–6:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University of Toronto
Tell us what you sell and we’ll find the people at University of Toronto most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction